Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Isabella Romeo, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 632-632
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
Bruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 375-375
Open Access | Times Cited: 74
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors
Roberta Bivacqua, Marilia Barreca, Virginia Spanò, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115136-115136
Open Access | Times Cited: 19
Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity
Carla Guijarro-Real, Mariola Plazas, Adrián Rodríguez‐Burruezo, et al.
Foods (2021) Vol. 10, Iss. 7, pp. 1503-1503
Open Access | Times Cited: 38
Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study
Anuj Kumar, Dwijesh Chandra Mishra, U. B. Angadi, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 33
Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 29
Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays
Fulvio Perrella, Federico Coppola, Alessio Petrone, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1048-1048
Open Access | Times Cited: 29
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Malabaricone C isolated from edible plants as a potential inhibitor of SARS-CoV-2 infection
Mutmainah, Yuta Murai, Ai Fujimoto, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta
Janina Auth, Maria Fröba, Maximilian Große, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10205-10205
Open Access | Times Cited: 26
An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19
Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, et al.
International Journal of Biological Macromolecules (2022) Vol. 209, pp. 244-257
Open Access | Times Cited: 18
Propolis efficacy on SARS-COV viruses: a review on antimicrobial activities and molecular simulations
Soumya Ghosh, Zainab T. Al‐Sharify, Mathabatha Frank Maleka, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 39, pp. 58628-58647
Open Access | Times Cited: 18
Digging for the Discovery of SARS-CoV-2 nsp12 Inhibitors: A Pharmacophore-Based and Molecular Dynamics Simulation Study
Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, et al.
Future Virology (2022) Vol. 17, Iss. 10, pp. 743-759
Open Access | Times Cited: 14
Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening
Md. Nazmus Samdani, Niaz Morshed, Rumman Reza, et al.
Molecular Diversity (2022) Vol. 27, Iss. 3, pp. 1067-1085
Open Access | Times Cited: 13
Nanoparticles and essential oils with antiviral activity on packaging and surfaces: An overview of their selection and application
Ronald Márquez, Jacob D. Zwilling, Franklin Zambrano, et al.
Journal of Surfactants and Detergents (2022) Vol. 25, Iss. 6, pp. 667-701
Open Access | Times Cited: 13
Chemical Composition of the Red Sea Green Algae Ulva lactuca: Isolation and In Silico Studies of New Anti-COVID-19 Ceramides
Enas E. Eltamany, Sameh S. Elhady, Marwa S. Goda, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 816-816
Open Access | Times Cited: 13
Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?
Jung‐Hyun Won, Howard Lee
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5457-5457
Open Access | Times Cited: 11
In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein–HSPA8 Complex Towards Developing COVID-19 Therapeutic Drugs
Liberty T. Navhaya, Thabe M. Matsebatlela, Mokgerwa Zacharia Monama, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1726-1726
Open Access | Times Cited: 1
Molecular Docking - Recent Advances
Erman Salih İstifli, Erman Salih, Sefika Feyza Maden, et al.
Biomedical engineering (2022)
Open Access | Times Cited: 5
In Silico Characterization of Masitinib Interaction with SARS‐CoV‐2 Main Protease
Ulises Martínez‐Ortega, Diego I. Figueroa‐Figueroa, Francisco Hernández‐Luis, et al.
ChemMedChem (2021) Vol. 16, Iss. 15, pp. 2339-2344
Open Access | Times Cited: 7
Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review
Yayun Xu, Yang Li, Longfei Wang, et al.
Drug Discoveries & Therapeutics (2021) Vol. 15, Iss. 6, pp. 289-299
Open Access | Times Cited: 7
Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
Zijing Ruan, Jiaxi Tang, Mingtang Zeng, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules
Ika Oktavianawati, Mardi Santoso, Mohd Fadzelly Abu Bakar, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 2
Synergistic Efficacy of Phytochemical, Antioxidant and Bactericidal Properties of the Aerial Essential Oil of Laggera crispata
Ololade Zacchaeus S, Iyadunni Adesola Anuoluwa, Adeyemi Adewale F, et al.
Pharmacognosy Journal (2021) Vol. 13, Iss. 5, pp. 1304-1311
Open Access | Times Cited: 4
General overview on SARS-CoV-2 and potential role of natural compounds as antiviral drugs targeting SARS-CoV-2 proteins
Saliha Dassamiour, Widad Ghebache, Hala Garbi
Arab Gulf Journal of Scientific Research (2022), pp. 15-36
Open Access | Times Cited: 1
Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline
Aldo Herrera-Rodulfo, Mariana Andrade-Medina, Mauricio Carrillo‐Tripp
Biomedical engineering (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top